ORTINGLOBE
ORTIN GLOBAL LIMITED (ORTINGLOBE) Stock Analysis
Ortin Global Limited is a pharmaceutical company engaged in formulations and drug distribution in India. It markets generic medicines and healthcare products through trade channels. The business focuses on affordable pharma supply. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹15.60
-8.48% 1W | +31.90% 52W
Market Cap
13 CR
P/E Ratio
–
52W High
₹21.3
52W Low
₹10.7
Div. Yield
0%
Beta
0.5
50 DMA
₹15.5
200 DMA
₹15.3
Profit Margin
0%
Inst. Own.
0%
⚡ APPROACHING SUPPORT
⚡ APPROACHING SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2011 | Mar 2012 | Jun 2012 |
|---|---|---|---|
| Sales | 19.81 | 19.77 | 15.93 |
| Expenses | 17.13 | 20.77 | 13.85 |
| Operating Profit | 2.68 | -1.00 | 2.08 |
| OPM % | 13.53% | -5.06% | 13.06% |
| Other Income | 0.01 | 0.19 | 0.03 |
| Interest | 0.55 | 0.98 | 1.12 |
| Depreciation | 0.34 | 0.39 | 0.33 |
| Profit before tax | 1.80 | -2.18 | 0.66 |
| Tax % | 33.33% | -11.93% | 33.33% |
| Net Profit | 1.20 | -1.92 | 0.44 |
| EPS in Rs | 3.24 | -1.14 | 0.26 |
No annual data
Shareholding Pattern
Promoters1.23%
FIIs6.53%
Public92.24%
Promoters1.23%
FIIs1.68%
Public97.08%
Promoters1.23%
FIIs1.68%
Public97.09%
Promoters1.23%
FIIs1.68%
Public97.10%
Promoters1.23%
FIIs1.80%
Public96.96%
Promoters21.51%
Public78.49%
Promoters1.23%
Public98.76%
Promoters1.23%
FIIs6.53%
Public92.24%
Promoters1.23%
FIIs1.68%
Public97.10%
Promoters1.23%
FIIs1.80%
Public96.96%
ORTINGLOBE
Holdings Analysis
Key strengths & risk signals
52
Overall
24
Fundamental
80
Technical
Risks (2)
LOW MARGIN! 0% profit margin - thin profits.
NEGATIVE MOMENTUM! Price declined across timeframes - down 8.5% (1 week), 1.6% (1 month), 9.3% (3 months).
Strengths (3)
BULLISH TREND! 50-day average (15.5) is above 200-day average (15.3) - positive signal.
GOOD YEAR! Stock gained 31.9% in the last year.
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 25,537 vs down days: 8,987. Ratio: 2.84x
Fundamental & Technical Analysis
52Overall
24Fundamental
80Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -74.4% (DECLINING, 2/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
0/10
LOW MARGIN! 0% profit margin - thin profits.
PEG Valuation
0/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 92.63% public ownership - higher volatility risk.
Stability Index
2/10
CAUTION! Company made loss in last quarter. Be careful.
Technical Breakdown
Moving Averages
10/10
BULLISH TREND! 50-day average (15.5) is above 200-day average (15.3) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (15.6) is above both moving averages.
Trend Pattern
10/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
10/10
GOOD YEAR! Stock gained 31.9% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 25,537 vs down days: 8,987. Ratio: 2.84x
RSI
3/5
NEUTRAL! RSI at 48.3 - balanced momentum.
52W Range
3/5
MID RANGE! Trading at 46.2% of 52W range - neutral zone.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 8.5% (1 week), 1.6% (1 month), 9.3% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.50 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ORTINGLOBE | ₹15.60 | – | – | -74.4% | – | +31.9% | 52 | APPROACHING SUPPORT | +50.0% | – | – | – |
| LASA | ₹5.90 | – | -253.8% | -42.1% | – | -50.5% | 40 | BREAKDOWN | -82.9% | -14.3% | -94.0% | -1,300.0% |
| VIVIMEDLAB | ₹5.50 | – | -231.3% | -27.9% | – | +12.7% | 42 | BREAKDOWN | +2,526.8% | +786.1% | -53.1% | -25.0% |
| MANGALAM | ₹32.60 | – | -16.5% | -14.3% | – | -54.4% | 44 | CONSOLIDATION | -44.9% | -43.3% | -0.2% | -15.2% |
| BIOFILCHEM | ₹32.60 | 108.7 | 1.4% | -1.9% | 70.7% | -23.4% | 54 | HIT RESISTANCE | -95.8% | -50.0% | +93.8% | +63.2% |
| VAISHALI | ₹8.20 | – | 4.1% | 18.0% | -15.2% | -27.4% | 57 | CONSOLIDATION | – | +278.0% | – | -15.0% |
| KREBSBIO | ₹56.00 | – | -55.9% | -23.1% | – | -28.3% | 49 | CONSOLIDATION | -52.8% | +8.7% | +27.3% | +2.9% |
| ALPA | ₹59.50 | 29.2 | 3.8% | 4.3% | 6.1% | -37.0% | 46 | APPROACHING SUPPORT | -91.5% | -28.6% | +25.1% | -23.9% |
Data from TradeAlone · Updated daily
No news tagged for ORTINGLOBE yet.
